CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration Hs-cTroponins for the prediction of recurrent cardiovascular events in patients with established CHD - A comparative analysis from the KAROLA study Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement Impact of Artificial Intelligence on Interventional Cardiology: From Decision-Making Aid to Advanced Interventional Procedure Assistance Timing and Causes of Unplanned Readmissions After Percutaneous Coronary Intervention: Insights From the Nationwide Readmission Database Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD

Guideline2016 Jan 14;37(3):267-315.

JOURNAL:Eur Heart J. Article Link

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)

Roffi M, Patrono C, ESC Scientific Document Group. Keywords: Acute cardiac care; Acute coronary syndromes; Angioplasty; Anticoagulation; Apixaban; Aspirin; Atherothrombosis; Beta-blockers; Bivalirudin; Bypass surgery; Cangrelor; Chest pain unit; Clopidogrel; Dabigatran; Diabetes; Early invasive strategy; Enoxaparin; European Society of Cardiology; Fondaparinux; Glycoprotein IIb/IIIa inhibitors; Guidelines; Heparin; High-sensitivity troponin; Myocardial ischaemia; Nitrates; Non-ST-elevation myocardial infarction; Platelet inhibition; Prasugrel; Recommendations; Revascularization; Rhythm monitoring; Rivaroxaban; Statin; Stent; Ticagrelor; Unstable angina; Vorapaxar

FULL TEXT PDF